UNSPSC 51112404: Procarbazine

This classification denotes a triazene compound with the molecular formula C12H19N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 35S93Y190K, chemically known as p-toluamide, n-isopropyl-.alpha.- (2-methylhydrazino)-, monohydrochloride but more generally known as procarbazine, which bears US NIH Compound Identifier 4915. European Medicines Agency schedules Procarbazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10057MIG.

UNSPSC 51112404 Procarbazine is a Commodity code covering the acquisition of procarbazine, an alkylating-agent chemotherapy drug used in cancer treatment protocols, particularly in Hodgkin lymphoma and brain tumor regimens. State and local governments procure procarbazine primarily through correctional health systems, public hospitals, and safety-net hospital networks that operate oncology departments and serve uninsured or underinsured populations. The drug is purchased as a finished pharmaceutical product—typically in oral capsule or injectable formulation—for inventory stocking and patient administration within institutional settings rather than through retail pharmacy channels.

The source provides no recent state or local contract opportunities tagged to this code, limiting visibility into current geographic activity, issuing-body concentration, or representative solicitation patterns.